317 related articles for article (PubMed ID: 21388249)
1. Potentiation by adrenaline of agonist-induced responses in normal human platelets in vitro.
Haaland HD; Holmsen H
Platelets; 2011; 22(5):328-37. PubMed ID: 21388249
[TBL] [Abstract][Full Text] [Related]
2. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro.
Steen VM; Holmsen H; Aarbakke G
Thromb Haemost; 1993 Sep; 70(3):506-13. PubMed ID: 8259557
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
4. Synergism between thrombin and epinephrine in human platelets: different dose-response relationships for aggregation and dense granule secretion.
Steen VM; Holmsen H
Thromb Haemost; 1985 Oct; 54(3):680-3. PubMed ID: 4089798
[TBL] [Abstract][Full Text] [Related]
5. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
6. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
Viisoreanu D; Gear A
Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868
[TBL] [Abstract][Full Text] [Related]
7. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
Martinson EA; Scheible S; Marx-Grunwitz A; Presek P
Thromb Haemost; 1998 Dec; 80(6):976-81. PubMed ID: 9869170
[TBL] [Abstract][Full Text] [Related]
8. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo functions of thrombin-treated platelets.
Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
[TBL] [Abstract][Full Text] [Related]
10. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
Krishnamurthi S; Joseph S; Kakkar VV
Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation.
Kinlough-Rathbone RL; Packham MA; Guccione MA; Richardson M; Harfenist EJ; Mustard JF
Thromb Haemost; 1991 Apr; 65(4):403-10. PubMed ID: 2057923
[TBL] [Abstract][Full Text] [Related]
12. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets.
Minuz P; Fumagalli L; Gaino S; Tommasoli RM; Degan M; Cavallini C; Lecchi A; Cattaneo M; Lechi Santonastaso C; Berton G
Biochem J; 2006 Nov; 400(1):127-34. PubMed ID: 16859489
[TBL] [Abstract][Full Text] [Related]
13. Potentiation by adrenaline of Ca2+ influx and mobilization in stimulated human platelets: dissociation from thromboxane generation and aggregation.
Powling MJ; Hardisty RM
Thromb Haemost; 1988 Apr; 59(2):212-5. PubMed ID: 3388294
[TBL] [Abstract][Full Text] [Related]
14. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
[TBL] [Abstract][Full Text] [Related]
15. Effects of sodium periodate on platelet functions.
Cazenave JP; Reimers HJ; Kinlough-Rathbone RL; Packham MA; Mustard JF
Lab Invest; 1976 May; 34(5):471-81. PubMed ID: 178961
[TBL] [Abstract][Full Text] [Related]
16. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
Fenn CG; Littleton JM
Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
[TBL] [Abstract][Full Text] [Related]
18. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
Koda M; Banno Y; Naganawa T
Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
[TBL] [Abstract][Full Text] [Related]
19. Unexpected effects of aurin tricarboxylic acid on human platelets.
Kinlough-Rathbone RL; Packham MA
Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
[TBL] [Abstract][Full Text] [Related]
20. Whole blood platelet aggregation in humans and animals: a comparative study.
Soloviev MV; Okazaki Y; Harasaki H
J Surg Res; 1999 Apr; 82(2):180-7. PubMed ID: 10090827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]